Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 29 October 2013 Agenda Topics- Advances in Enabling Discovery Technologies
- 3D Cell-based Assays
- Biologics
- High Content Assays
- High Content Flow Cytometry
- Label Free Screening Technologies
- Model Organisms e.g. C. elegans
- Patient Derived iPSC Cells
- Screening Stem Cells
- Target ID and Validation
- Natural Product Diversity & Novel Chemistries to Fill in the RnD Pipeline
- Addressing Emerging & Challenging Targets
- Assessing Natural Product Toxicities
- Bioassay Based Fractionation
- Natural Product Screening
- Novel Chemical Library Designs
- Repurposing Existing Approved Drugs
- Synthetic Biology for Complex Chemistries
Sponsorship and Exhibition OpportunitiesAaron Woodley, Sales & Marketing Manager a.woodley@selectbiosciences.com +44 (0)1787 315129
|
SpeakersGerardo Turcatti, Director of the Biomolecular Screening Facility, Ecole Polytechnique Federale de Lausanne Said Goueli, Group Leader, Promega Corporation Frederic Bard, Principal Investigator, Institute for Molecular and Cell Biology Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center Horst Flotow, Head, Singapore Screening Centre, Experimental Therapeutics Centre Mark Butler, Senior Research Fellow, University of Queensland Premkumar Arumugam, Director, Biology, GVK Biosciences Spencer Shorte, Director, Institut Pasteur Lixin Zhang, Professor, Chinese Academy of Sciences Stephen Pak, Assistant Professor, University of Pittsburgh School of Medicine Cedric Gaggioli, Senior Post Doctoral Fellow, University of Nice Jan Lichtenberg, CEO, InSphero AG Mark Frattini, Associate Professor of Clinical Medicine, Columbia University Medical Center
|